{"nct_id":"NCT05076149","title":"A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2021-10-27","start_date_type":"ACTUAL","primary_completion_date":"2023-05-18","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRTX"]}